Zhejiang International Scientific Research, Medical Instrument and Equipment Technology Exchange Exhibition was founded in 1988, co-sponsored by Zhejiang Provincial Health Commission and Zhejiang Provincial Department of Science and Technology, and has gone through 33 springs and autumns. Since its inception, the exhibition has always adhered to the concept of organizing exhibitions and conferences of "learning from others' strengths and expanding exchanges", based in Zhejiang, looking at the world, and constantly playing its role as a platform to promote international medical science and technology exchanges and cooperation, and help Zhejiang build a life and health science and technology innovation center. .

Exhibition time:

April 12 to April 14, 2021 09:00-16:30

09:00-12:00, April 15, 2021

Exhibition location:Hangzhou International Expo Center (No. 353, Benjing Avenue, Qianjiang Century City, Xiaoshan District, Hangzhou)

Please pay attention to the "Zhejiang International Medical Exhibition" public account, click on the exhibition registration below to sign up!

During the exhibition, Ningbo Aocheng will bring its latest product-Placental Growth Factor (PLGF) testing reagents and innovative solutions to the exhibition, and we sincerely invite you to visit.

Ningbo Aocheng Biotechnology Co., Ltd.'s new test product-Placental Growth Factor (PLGF) Test Kit-obtained the "Practical Guide for Early Preeclampsia Screening and Prevention in Early Pregnancy" issued by the International Federation of Obstetrics and Gynecology (FIGO) in 2019 and In 2020, the “Guidelines for the Diagnosis and Treatment of Hypertension in Pregnancy” issued by the Obstetrics and Gynecology Branch of the Chinese Medical Association’s “Guidelines for the Diagnosis and Treatment of Hypertension in Pregnancy” is the strongest level recommendation, opening a new chapter in the scientific and standardized management of hypertension and preeclampsia in pregnancy in my country.

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment.

At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension. We will be committed to providing leading clinical diagnosis solutions for maternal and child health. Promote the standardized management of perinatal preeclampsia in my country, and contribute to the predictive management of preeclampsia in the world.